These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16288424)

  • 1. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (I)].
    Mínguez-Castellanos A; Escamilla-Sevilla F
    Rev Neurol; 2005 Nov 16-30; 41(10):604-14. PubMed ID: 16288424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (II)].
    Mínguez-Castellanos A; Escamilla-Sevilla F
    Rev Neurol; 2005 Dec 1-15; 41(11):684-93. PubMed ID: 16317638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995.
    Kupsch A; Oertel WH; Earl CD; Sautter J
    J Neural Transm Suppl; 1995; 46():193-207. PubMed ID: 8821056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease.
    Kordower JH
    Ann Neurol; 2003; 53 Suppl 3():S120-32; discussion S132-4. PubMed ID: 12666104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
    Isacson O; Bjorklund LM; Schumacher JM
    Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application.
    Yasuhara T; Date I
    Cell Transplant; 2007; 16(2):125-32. PubMed ID: 17474294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
    Hodaie M; Neimat JS; Lozano AM
    Neurosurgery; 2007 Jan; 60(1):17-28; discussion 28-30. PubMed ID: 17228250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of ex vivo gene therapy in the treatment of Parkinson's disease.
    Raymon HK; Thode S; Gage FH
    Exp Neurol; 1997 Mar; 144(1):82-91. PubMed ID: 9126156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular transplants for Parkinson's disease].
    Guridi J; Herrero MT; Luquin MR; Obeso JA
    Neurologia; 1991 May; 6(5):175-83. PubMed ID: 1873045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?
    Lindvall O; Wahlberg LU
    Exp Neurol; 2008 Jan; 209(1):82-8. PubMed ID: 17963752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal medulla in neural grafting and neural plasticity.
    Hansen JT; Gash DM
    Microsc Res Tech; 1994 Oct; 29(2):155-60. PubMed ID: 7812037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise review: therapeutic strategies for Parkinson disease based on the modulation of adult neurogenesis.
    Geraerts M; Krylyshkina O; Debyser Z; Baekelandt V
    Stem Cells; 2007 Feb; 25(2):263-70. PubMed ID: 17082225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging restorative treatments for Parkinson's disease.
    Deierborg T; Soulet D; Roybon L; Hall V; Brundin P
    Prog Neurobiol; 2008 Aug; 85(4):407-32. PubMed ID: 18586376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stem cells: solution to the problem of transplants in Parkinson's disease?].
    Linazasoro G
    Neurologia; 2003 Mar; 18(2):74-100. PubMed ID: 12610757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neural transplants en Parkinson disease: clinical results of 10 years of experience. Group of Neural Transplants of the CPH].
    López-Lozano JJ; Mata M; Bravo G
    Rev Neurol; 2000 Jun 1-15; 30(11):1077-83. PubMed ID: 10904957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.
    San Sebastián W; Guillén J; Manrique M; Belzunegui S; Ciordia E; Izal-Azcárate A; Garrido-Gil P; Vázquez-Claverie M; Luquin MR
    Brain; 2007 May; 130(Pt 5):1306-16. PubMed ID: 17439984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
    McLeod M; Hong M; Mukhida K; Sadi D; Ulalia R; Mendez I
    Eur J Neurosci; 2006 Jul; 24(2):361-70. PubMed ID: 16903847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.